NCT00003458View on ClinicalTrials.gov

Antineoplaston Therapy in Treating Children With Brain Tumors

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 1996

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Childhood Brain Tumors
Interventions
DRUG

Antineoplaston therapy (Atengenal + Astugenal)

Children with a brain tumor will receive Antineoplaston therapy (Atengenal + Astugenal).

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston

Sponsors
All Listed Sponsors
lead

Burzynski Research Institute

OTHER